Dianthus Therapeutics (DNTH) Research & Development: 2017-2025
Historic Research & Development for Dianthus Therapeutics (DNTH) over the last 7 years, with Sep 2025 value amounting to $32.5 million.
- Dianthus Therapeutics' Research & Development rose 27.19% to $32.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.2 million, marking a year-over-year increase of 71.30%. This contributed to the annual value of $83.1 million for FY2024, which is 153.05% up from last year.
- Per Dianthus Therapeutics' latest filing, its Research & Development stood at $32.5 million for Q3 2025, which was up 23.76% from $26.3 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Research & Development ranged from a high of $32.5 million in Q3 2025 and a low of $5.8 million during Q1 2023.
- In the last 3 years, Dianthus Therapeutics' Research & Development had a median value of $18.1 million in 2024 and averaged $18.3 million.
- Per our database at Business Quant, Dianthus Therapeutics' Research & Development fell by 10.68% in 2023 and then spiked by 220.90% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Research & Development (Quarterly) stood at $9.8 million in 2022, then dropped by 10.68% to $8.8 million in 2023, then skyrocketed by 200.80% to $26.4 million in 2024, then increased by 27.19% to $32.5 million in 2025.
- Its last three reported values are $32.5 million in Q3 2025, $26.3 million for Q2 2025, and $27.0 million during Q1 2025.